WEBULL
News
INCPF
2.050
NaN%
--
InnoCare Wins NMPA Approval Of Phase II Trial Of ICP-488 In Cutaneous Lupus Erythematosus
NASDAQ · 12/23/2025 11:11
InnoCare Pharma Ltd. (9969) Gets a Buy from UBS
TipRanks · 12/17/2025 00:27
InnoCare Pharma achieves primary endpoint in Phase 2b study of orelabrutinib
TipRanks · 12/15/2025 12:10
InnoCare Pharma announces phase IIb study of orelabrutinib met primary endpoint
TipRanks · 12/14/2025 16:30
InnoCare Pharma Advances Orelabrutinib with Positive SLE Trial Results
TipRanks · 12/14/2025 10:38
InnoCare Pharma announces NMPA approval for zurletrectinib in China
TipRanks · 12/11/2025 11:20
InnoCare Pharma Gains Approval for Innovative Cancer Treatment in China
TipRanks · 12/11/2025 10:37
Zenas BioPharma: Two Late-Stage Catalysts And A $2B InnoCare Deal
Seeking Alpha · 10/09/2025 12:00
Zenas climbs on licensing deal with InnoCare
Seeking Alpha · 10/08/2025 13:03
Weekly Report: what happened at INCPF last week (0908-0912)?
Weekly Report · 09/15/2025 11:14
Weekly Report: what happened at INCPF last week (0901-0905)?
Weekly Report · 09/08/2025 11:16
Weekly Report: what happened at INCPF last week (0825-0829)?
Weekly Report · 09/01/2025 11:11
Weekly Report: what happened at INCPF last week (0818-0822)?
Weekly Report · 08/25/2025 11:22
Weekly Report: what happened at INCPF last week (0811-0815)?
Weekly Report · 08/18/2025 11:14
Weekly Report: what happened at INCPF last week (0804-0808)?
Weekly Report · 08/11/2025 11:21
Weekly Report: what happened at INCPF last week (0728-0801)?
Weekly Report · 08/04/2025 11:24
Weekly Report: what happened at INCPF last week (0721-0725)?
Weekly Report · 07/28/2025 11:24
Weekly Report: what happened at INCPF last week (0714-0718)?
Weekly Report · 07/21/2025 11:14
Weekly Report: what happened at INCPF last week (0707-0711)?
Weekly Report · 07/14/2025 11:24
Weekly Report: what happened at INCPF last week (0630-0704)?
Weekly Report · 07/07/2025 11:15
More
Webull provides a variety of real-time INCPF stock news. You can receive the latest news about Innocare Pharma through multiple platforms. This information may help you make smarter investment decisions.
About INCPF
InnoCare Pharma Ltd is a China-based company mainly engaged in the research and development, production and commercialization of biopharmaceuticals. The Company focuses on areas with unmet clinical needs, such as oncology and autoimmune diseases. The Company's primary product pipeline includes Orelabrutinib, Tafasitamab, ICP-490, ICP-B02, ICP-248, ICP-B05, ICP-332, ICP-488, ICP-192, ICP-723, ICP-033 and ICP-189, and others. Its products are mainly used to treat hematological tumors, solid tumors and autoimmune diseases. The Company is also developing products for the treatment of autoimmune diseases caused by abnormal T cell function. The Company conducts its businesses in domestic and overseas markets.